Cargando…
Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma
SIMPLE SUMMARY: A prospective evaluation of laparoscopic microwave ablation (MWA) of hepatocellular carcinoma is underutilized and predictors of patient selection and survival in this setting are not well characterized. Preoperative single lesions, “pusher” radiographic presentation, and total bilir...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093561/ https://www.ncbi.nlm.nih.gov/pubmed/37046625 http://dx.doi.org/10.3390/cancers15071965 |
_version_ | 1785023616016973824 |
---|---|
author | Martin, Robert C. G. Woeste, Matthew Egger, Michael E. Scoggins, Charles R. McMasters, Kelly M. Philips, Prejesh |
author_facet | Martin, Robert C. G. Woeste, Matthew Egger, Michael E. Scoggins, Charles R. McMasters, Kelly M. Philips, Prejesh |
author_sort | Martin, Robert C. G. |
collection | PubMed |
description | SIMPLE SUMMARY: A prospective evaluation of laparoscopic microwave ablation (MWA) of hepatocellular carcinoma is underutilized and predictors of patient selection and survival in this setting are not well characterized. Preoperative single lesions, “pusher” radiographic presentation, and total bilirubin < 2, and AFP < 20 ng/mL independently predict PFS and OS following operative MWA. ABSTRACT: Background: Laparoscopic microwave ablation (MWA) of hepatocellular carcinoma is underutilized and predictors of survival in this setting are not well characterized. Methods: The prognostic value of clinicopathologic variables was evaluated on progression-free survival (PFS) and overall survival (OS) by univariate and multivariate analyses. The aim of this study was to evaluate a preferred laparoscopic MWA approach in HCC patients that are not candidates for percutaneous ablation and further classify clinicopathologic factors that may predict survival outcomes following operative MWA in the setting of primary HCC. Results: 184 patients with HCC (median age 66, (33–86), 70% male) underwent laparoscopic MWA (N = 162, 88% laparoscopic) compared to 12% undergoing open MWA (N = 22). Median PFS was 29.3 months (0.2–170) and OS was 44.2 months (2.8–170). Ablation success was confirmed in 100% of patients. Ablation recurrence occurred in 3% (6/184), and local/hepatic recurrence occurred in 34%, at a median time of 19 months (9–18). Distant progression was noted in 8%. Median follow up was 34.1 months (6.4–170). Procedure-related complications were recorded in six (9%) patients with one 90-day mortality. Further, >1 lesion, AFP levels ≥ 80 ng/mL, and an “invader” on pre-operative radiology were associated with increased risk of progression (>1 lesion HR 2.92, 95% CI 1.06 –7.99, p = 0.04, AFP ≥ 80 ng/mL HR 4.16, 95% CI 1.71–10.15, p = 0.002, Invader HR 3.16, 95% CI 1.91–9.15, p = 0.002 ) and mortality (>1 lesion HR 3.62, 95% CI 1.21–10.81, p = 0.02], AFP ≥ 80 ng/mL HR 2.87, 95% CI 1.12–7.35, p = 0.01, Invader HR 3.32, 95% CI 1.21–9.81, p = 0.02). Conclusions: Preoperative lesion number, AFP ≥ 80 ng/mL, and an aggressive imaging characteristic (Invader) independently predict PFS and OS following laparoscopic operative MWA. |
format | Online Article Text |
id | pubmed-10093561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100935612023-04-13 Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma Martin, Robert C. G. Woeste, Matthew Egger, Michael E. Scoggins, Charles R. McMasters, Kelly M. Philips, Prejesh Cancers (Basel) Article SIMPLE SUMMARY: A prospective evaluation of laparoscopic microwave ablation (MWA) of hepatocellular carcinoma is underutilized and predictors of patient selection and survival in this setting are not well characterized. Preoperative single lesions, “pusher” radiographic presentation, and total bilirubin < 2, and AFP < 20 ng/mL independently predict PFS and OS following operative MWA. ABSTRACT: Background: Laparoscopic microwave ablation (MWA) of hepatocellular carcinoma is underutilized and predictors of survival in this setting are not well characterized. Methods: The prognostic value of clinicopathologic variables was evaluated on progression-free survival (PFS) and overall survival (OS) by univariate and multivariate analyses. The aim of this study was to evaluate a preferred laparoscopic MWA approach in HCC patients that are not candidates for percutaneous ablation and further classify clinicopathologic factors that may predict survival outcomes following operative MWA in the setting of primary HCC. Results: 184 patients with HCC (median age 66, (33–86), 70% male) underwent laparoscopic MWA (N = 162, 88% laparoscopic) compared to 12% undergoing open MWA (N = 22). Median PFS was 29.3 months (0.2–170) and OS was 44.2 months (2.8–170). Ablation success was confirmed in 100% of patients. Ablation recurrence occurred in 3% (6/184), and local/hepatic recurrence occurred in 34%, at a median time of 19 months (9–18). Distant progression was noted in 8%. Median follow up was 34.1 months (6.4–170). Procedure-related complications were recorded in six (9%) patients with one 90-day mortality. Further, >1 lesion, AFP levels ≥ 80 ng/mL, and an “invader” on pre-operative radiology were associated with increased risk of progression (>1 lesion HR 2.92, 95% CI 1.06 –7.99, p = 0.04, AFP ≥ 80 ng/mL HR 4.16, 95% CI 1.71–10.15, p = 0.002, Invader HR 3.16, 95% CI 1.91–9.15, p = 0.002 ) and mortality (>1 lesion HR 3.62, 95% CI 1.21–10.81, p = 0.02], AFP ≥ 80 ng/mL HR 2.87, 95% CI 1.12–7.35, p = 0.01, Invader HR 3.32, 95% CI 1.21–9.81, p = 0.02). Conclusions: Preoperative lesion number, AFP ≥ 80 ng/mL, and an aggressive imaging characteristic (Invader) independently predict PFS and OS following laparoscopic operative MWA. MDPI 2023-03-25 /pmc/articles/PMC10093561/ /pubmed/37046625 http://dx.doi.org/10.3390/cancers15071965 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Martin, Robert C. G. Woeste, Matthew Egger, Michael E. Scoggins, Charles R. McMasters, Kelly M. Philips, Prejesh Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma |
title | Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma |
title_full | Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma |
title_fullStr | Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma |
title_full_unstemmed | Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma |
title_short | Patient Selection and Outcomes of Laparoscopic Microwave Ablation of Hepatocellular Carcinoma |
title_sort | patient selection and outcomes of laparoscopic microwave ablation of hepatocellular carcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093561/ https://www.ncbi.nlm.nih.gov/pubmed/37046625 http://dx.doi.org/10.3390/cancers15071965 |
work_keys_str_mv | AT martinrobertcg patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma AT woestematthew patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma AT eggermichaele patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma AT scogginscharlesr patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma AT mcmasterskellym patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma AT philipsprejesh patientselectionandoutcomesoflaparoscopicmicrowaveablationofhepatocellularcarcinoma |